Pulmonary arterial hypertension treatments

Applications to fund PAH treatments may be considered by the Ministry of Health or Pharmac's PAH Panel.

Decision on how we fund PAH treatments

Following our consultation in May, we have announced the Special Authority funding criteria for PAH treatments. 

Since 1 August 2023, all PAH treatments now follow a standard special authority application process. Applications no longer come to the PAH Panel.

Decision for Pulmonary Arterial Hypertension (PAH) treatments

Pulmonary Arterial Hypertension (PAH) Panel

The PAH Panel met every 2 weeks.

Members of the panel

  • Dr Howard Wilson – General Practitioner/Pharmacologist
  • Dr Andrew Aitken – Cardiologist
  • Dr Lutz Beckert – Respiratory Physician
  • Dr Clare O'Donnell – Paediatric Congenital Cardiologist
  • Dr Kenneth Whyte – Respiratory Physician

Contact details for the panel 

Email PAH@pharmac.govt.nz

Fax 04 974 4858

Phone 0800 023 588 option 5

Post PAH Panel Coordinator
P O Box 10-254